The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

54 articles for F Xu


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Polycyclic Polyprenylated Acylphloroglucinol Congeners from Hypericum scabrum.EBI
Peking Union Medical College
Discovery of 3-benzyl-1,3-benzoxazine-2,4-dione analogues as allosteric mitogen-activated kinase kinase (MEK) inhibitors and anti-enterovirus 71 (EV71) agents.EBI
Peking University Health Science Center
Synthesis, antitumor evaluation and molecular docking studies of [1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine derivatives.EBI
Taizhou Vocational & Technical College
Development of novel proteasome inhibitors based on phthalazinone scaffold.EBI
Peking University Health Science Center
4-Oxo-1,4-dihydro-quinoline-3-carboxamides as BACE-1 inhibitors: synthesis, biological evaluation and docking studies.EBI
Peking University Health Science Center
Discovery of N-(3-((7H-purin-6-yl)thio)-4-hydroxynaphthalen-1-yl)-sulfonamide derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: Synthesis and biological evaluation. Part III.EBI
Shandong University
Discovery of 4-amino-2-(thio)phenol derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: synthesis and biological evaluation. Part II.EBI
Shandong University
Novel tetrahydropyran analogs as dipeptidyl peptidase IV inhibitors: profile of clinical candidate (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine (23).EBI
Merck Research Laboratories
Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3.EBI
Amgen
Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A2A adenosine receptor.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.EBI
Kyoto Pharmaceutical University
Discovery of the First Potent DYRK2 Proteolysis Targeting Chimera Degraders.EBI
Sun Yat-sen University
Discovery of anti-inflammatory natural flavonoids: Diverse scaffolds and promising leads for drug discovery.EBI
Hangzhou Normal University
Discovery of Effective Dual PROTAC Degraders for Neurodegenerative Disease-Associated Aggregates.EBI
Sun Yat-sen University
Targeting EGFR degradation by autophagosome degraders.EBI
Jinan University
Discovery of Novel EBI
China Pharmaceutical University
Cyclopropenone, Cyclopropeniminium Ion, and Cyclopropenethione as Novel Electrophilic Warheads for Potential Target Discovery of Triple-Negative Breast Cancer.EBI
Jinan University
Dual degradation mechanism of GPX4 degrader in induction of ferroptosis exerting anti-resistant tumor effect.EBI
Peking University
Precise Conformational Control Yielding Highly Potent and Exceptionally Selective BRD4 Degraders with Strong Antitumor Activity.EBI
University of Michigan
Discovery of Small-Molecule Degraders for Alpha-Synuclein Aggregates.EBI
Sun Yat-Sen University
Design, synthesis and biological evaluation of pyrrolopyrimidine derivatives as novel and selective positive modulator of the small conductance CaEBI
Hebei Medical University
Structure-Based Ligand Discovery Targeting the Transmembrane Domain of Frizzled Receptor FZD7.EBI
Shanghaitech University
Targeted Degradation of Alpha-Synuclein by Autophagosome-Anchoring Chimera Peptides.EBI
Sun Yat-Sen University
Structure-Based Drug Design and Synthesis of Novel EBI
Shenyang Pharmaceutical University
Dammarane-type leads panaxadiol and protopanaxadiol for drug discovery: Biological activity and structural modification.EBI
Shenyang Pharmaceutical University
Optimization of 2-aminothiazole derivatives as CCR4 antagonists.EBI
Amgen
Ynamide Electrophile for the Profiling of Ligandable Carboxyl Residues in Live Cells and the Development of New Covalent Inhibitors.EBI
Jinan University
Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells.EBI
Jinan University
Cannabidiol Protects Human Skin Keratinocytes from Hydrogen-Peroxide-Induced Oxidative Stress via Modulation of the Caspase-1-IL-1β Axis.EBI
University of Rhode Island
Elucidation of Distinct Modular Assemblies of Smoothened Receptor by Bitopic Ligand Measurement.EBI
Shanghaitech University
Structure-Activity Study of Nitazoxanide Derivatives as Novel STAT3 Pathway Inhibitors.EBI
Peking University Health Science Center
Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195).EBI
Pfizer
Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists.EBI
Dalian Institute of Chemical Physics
Design and synthesis of selective degraders of EGFREBI
Jinan University
Design and synthesis of tripeptidyl furylketones as selective inhibitors against the β5 subunit of human 20S proteasome.EBI
Peking University Health Science Center
Discovery and optimization of 2-aminopyridine derivatives as novel and selective JAK2 inhibitors.EBI
East China University of Science & Technology
Colocalization Strategy Unveils an Underside Binding Site in the Transmembrane Domain of Smoothened Receptor.EBI
Shanghaitech University
Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.EBI
China Pharmaceutical University
Discovery of a GPR40 Superagonist: The Impact of Aryl Propionic Acid α-Fluorination.EBI
Janssen Research & Development
Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression.EBI
TBA
Design, synthesis and structure-activity relationship study of aminopyridine derivatives as novel inhibitors of Janus kinase 2.EBI
East China University of Science & Technology
Design, synthesis, and biological evaluation of truncated deguelin derivatives as Hsp90 inhibitors.EBI
China Pharmaceutical University
Discovery of Novel Quinoline-Chalcone Derivatives as Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity.EBI
China Pharmaceutical University
Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as α1A/1D-AR subselective antagonists for BPH.EBI
Jinan University
Structure-based optimization of click-based histone deacetylase inhibitors.EBI
Nankai University
Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression.EBI
University of Michigan Comprehensive Cancer Center
2-Substituted-thio-N-(4-substituted-thiazol/1H-imidazol-2-yl)acetamides as BACE1 inhibitors: Synthesis, biological evaluation and docking studies.EBI
Peking University Health Science Center
PYRIDINE DERIVATIVESBDB
Hoffmann-La Roche
Methyl Yellow: A Potential Drug Scaffold for Parkinson's Disease.BDB
Northeast Ohio Medial University